Profil
Mark J.
Murray was the founder of Protiva Biotherapeutics, Inc., founded in 2000, where the title held was President & Chief Executive Officer from 2000 to 2008.
The current job is Director at Genevant Sciences Corp.
Former job includes President, Chief Executive Officer & Director at Arbutus Biopharma Corp.
from 2011 to 2019.
Education includes a doctorate from Oregon Health & Science University.
Postes actifs de Mark Murray
| Sociétés | Poste | Début |
|---|---|---|
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | - |
Anciens postes connus de Mark Murray
| Sociétés | Poste | Fin |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Directeur Général | 24/06/2019 |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Général | 02/12/2008 |
Formation de Mark Murray
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Oregon Health & Science University
Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















